Boycott
发表于 2025-3-23 13:41:09
,Durchführung der Lithiumtherapie,synthesis, inhibitors of adrenal androgen synthesis, and first and second generation of antiandrogens. These agents exert a good control of the disease in terms of both overall survival and reduction in the incidence and severity of skeletal adverse events. In hormone-naïve patients, luteinizing hor
愤世嫉俗者
发表于 2025-3-23 17:51:04
http://reply.papertrans.cn/19/1897/189691/189691_12.png
largesse
发表于 2025-3-23 21:07:53
http://reply.papertrans.cn/19/1897/189691/189691_13.png
Atheroma
发表于 2025-3-24 01:24:52
http://reply.papertrans.cn/19/1897/189691/189691_14.png
DNR215
发表于 2025-3-24 03:29:39
Circulating Tumor Cells (CTCs) and Metastatic Prostate Cancer (mPCa),g tumor cells (CTCs) meet the criteria required for a surrogate endpoint, particularly in mPCa..The main open question about the clinical management of mPCa is discussed, with the intent to underscore how the extended use of CTC detection and characterization can offer further benefit to these patients.
谦卑
发表于 2025-3-24 08:27:37
Book 2017respect to biology, pathology, diagnosis, and treatment are described, providing readers with an excellent understanding of the mechanisms of metastasis formation, the characteristics of metastases, their aggressiveness, and prognostic factors for treatment response. The coverage includes discussion
Arteriography
发表于 2025-3-24 10:39:55
Preparations, Dosage, and Control,g tumor cells (CTCs) meet the criteria required for a surrogate endpoint, particularly in mPCa..The main open question about the clinical management of mPCa is discussed, with the intent to underscore how the extended use of CTC detection and characterization can offer further benefit to these patients.
LIEN
发表于 2025-3-24 15:51:11
Studies in Human Ecology and Adaptationr PFS and OS than those with 5–20 BMTs . It should, however, be taken into account that among the predictors of prognosis, coexisting non-osseous metastatic disease is an important determinant of prognosis in patients with BMTs .
报复
发表于 2025-3-24 20:41:09
http://reply.papertrans.cn/19/1897/189691/189691_19.png
财主
发表于 2025-3-25 01:42:08
http://reply.papertrans.cn/19/1897/189691/189691_20.png